Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Allocca, Mariangela, Chaparro, María, Gonzalez, Haidee Aleman, Bosca-Watts, Marta Maia, Palmela, Carolina, D’Amico, Ferdinando, Zacharopoulou, Eirini, Kopylov, Uri, Ellul, Pierre, Bamias, Giorgos, Ntelis, Vassilios, Lahat, Adi, Mantzaris, Gerassimos J, Papaconstantinou, Ioannis, Katsanos, Konstantinos, Uspenskaya, Yulia, Christodoulou, Dimitrios, Ben Horin, Shomron, Peyrin-Biroulet, Laurent, Torres, Joanna, Sebastian, Shaji, Gisbert, Javier P, Danese, Silvio, Fiorino, Gionata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693947/
https://www.ncbi.nlm.nih.gov/pubmed/33142843
http://dx.doi.org/10.3390/jcm9113533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693947/
https://www.ncbi.nlm.nih.gov/pubmed/33142843
http://dx.doi.org/10.3390/jcm9113533

Ejemplares similares